T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.72% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBAI
2051
DELISTED
Lakeland Bancorp Inc
LBAI
| $587K | ﹤0.01% |
33,345
+978
| +3% | +$17.4K |
|
2052
Arrow Financial
AROW
$728M
| $586K | ﹤0.01% |
17,818
+3,070
| +21% | +$99.2K |
|
2053
Recursion Pharmaceuticals
RXRX
$1.7B
| $585K | ﹤0.01% |
75,919
+39,713
| +110% | +$389K |
|
|
EVOP
2054
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $584K | ﹤0.01% |
17,250
+631
| +4% | +$21.2K |
|
2055
Nektar Therapeutics
NKTR
$2.49B
| $583K | ﹤0.01% |
17,192
-250
| -1% | -$12.1K |
|
2056
Protolabs
PRLB
$2.19B
| $583K | ﹤0.01% |
22,830
+5,604
| +33% | +$166K |
|
2057
Dillards
DDS
$9.24B
| $581K | ﹤0.01% |
1,799
-157
| -8% | -$51.1K |
|
|
SP
2058
DELISTED
SP Plus Corporation
SP
| $581K | ﹤0.01% |
16,736
-260
| -2% | -$8.97K |
|
|
ECHO
2059
EchoStar
ECHO
$26.5B
| $580K | ﹤0.01% |
34,778
+14
| +0% | +$243 |
|
2060
Vicor
VICR
$10.6B
| $580K | ﹤0.01% |
10,787
+978
| +10% | +$51.4K |
|
|
ATSG
2061
DELISTED
Air Transport Services Group
ATSG
| $580K | ﹤0.01% |
22,326
+1,514
| +7% | +$41.7K |
|
2062
Amylyx Pharmaceuticals
AMLX
$2.39B
| $579K | ﹤0.01% |
+15,683
| New | +$557K |
|
2063
Ingles Markets
IMKTA
$1.66B
| $578K | ﹤0.01% |
5,987
+186
| +3% | +$17.5K |
|
2064
Sonic Automotive
SAH
$2.54B
| $578K | ﹤0.01% |
11,728
-3,045
| -21% | -$146K |
|
2065
Cushman & Wakefield Ltd
CWK
$3.35B
| $577K | ﹤0.01% |
46,278
+2,215
| +5% | +$25.6K |
|
|
HPP
2066
Hudson Pacific Properties
HPP
$784M
| $575K | ﹤0.01% |
8,436
+274
| +3% | +$20.3K |
|
2067
Myriad Genetics
MYGN
$299M
| $574K | ﹤0.01% |
39,571
+1,077
| +3% | +$20.1K |
|
2068
Astec Industries
ASTE
$991M
| $573K | ﹤0.01% |
14,088
+355
| +3% | +$14.3K |
|
|
ADAM
2069
Adamas Trust
ADAM
$910M
| $572K | ﹤0.01% |
55,838
+1,281
| +2% | +$13.6K |
|
2070
Ligand Pharmaceuticals
LGND
$5.83B
| $568K | ﹤0.01% |
8,496
-4,772
| -36% | -$310K |
|
|
RC
2071
Ready Capital
RC
$299M
| $567K | ﹤0.01% |
50,865
+1,514
| +3% | +$18.2K |
|
2072
XPEL
XPEL
$1.38B
| $564K | ﹤0.01% |
9,389
-88
| -0.9% | -$5.62K |
|
|
PGRE
2073
DELISTED
Paramount Group
PGRE
| $563K | ﹤0.01% |
94,714
+2,171
| +2% | +$13.6K |
|
|
HAYN
2074
DELISTED
Haynes International, Inc.
HAYN
| $563K | ﹤0.01% |
12,323
-289
| -2% | -$13.6K |
|
2075
Ennis
EBF
$559M
| $561K | ﹤0.01% |
25,305
+8,312
| +49% | +$184K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.